General Information of the Compound
| Compound ID |
CP0527506
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[[3-[5-[(dimethylamino)methyl]pyridin-2-yl]imidazo[1,2-a]pyridin-6-yl]methyl]-N-methyl-5-[3-methyl-5-(1,3,5-trimethylpyrazol-4-yl)pyridin-2-yl]-1,3,4-oxadiazol-2-amine
Show/Hide
|
||||||||||||||||||
| Formula |
C31H34N10O
|
||||||||||||||||||
| Molecular Weight |
562.682
|
||||||||||||||||||
| Canonical SMILES |
CN(C)Cc1ccc(nc1)-c1cnc2ccc(CN(C)c3nnc(o3)-c3ncc(cc3C)-c3c(C)nn(C)c3C)cn12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H34N10O/c1-19-12-24(28-20(2)37-40(7)21(28)3)14-34-29(19)30-35-36-31(42-30)39(6)17-23-9-11-27-33-15-26(41(27)18-23)25-10-8-22(13-32-25)16-38(4)5/h8-15,18H,16-17H2,1-7H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
BFKCQNVNPUJABZ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT01661, Tyrosine-protein kinase receptor TYRO3
Protein ID: PT01128, Tyrosine-protein kinase receptor UFO